Skip to main content
. 2024 Apr 26;16(4):2472–2481. doi: 10.21037/jtd-24-309

Table 1. Summary of patient characteristics.

Characteristics Group A (n=21) Group B (n=17) P value
Age (years) 65±7.3 68±7.0 0.26
Sex, male 14 (66.7) 10 (58.8) 0.62
Smoking history 5 (23.8) 9 (52.9) 0.06
Drinking history 8 (38.1) 10 (58.8) 0.20
Malignant-tumors history 3 (14.3) 2 (11.8) 0.82
Concomitant diseases
   Hypertension 9 (42.9) 5 (29.4) 0.39
   Diabetes 7 (33.3) 4 (23.5) 0.51
BMI (kg/m2) 21.2±2.4 20.6±2.4 0.44
Tumor location 0.28
   Upper 5 (23.8) 4 (23.5)
   Middle 13 (61.9) 7 (41.2)
   Lower 3 (14.3) 6 (35.3)
ASA Physical Status Classification 0.91
   I 9 (42.9) 8 (47.1)
   II 10 (47.6) 8 (47.1)
   III 2 (9.5) 1 (5.9)
Neoadjuvant chemotherapy 1 (4.8) 1 (5.9) 0.88
Neoadjuvant radiation 0 (0) 0 (0) >0.99
Pathological type 0.82
   SCC 18 (85.7) 15 (88.2)
   AC 3 (14.3) 2 (11.8)
T 0.55
   1 14 (66.6) 14 (82.4)
   2 5 (23.8) 3 (17.6)
   3 1 (4.8) 0 (0)
   4 1 (4.8) 0 (0)
N 0.70
   0 18 (85.6) 14 (82.3)
   1 1 (4.8) 1 (5.9)
   2 1 (4.8) 2 (11.8)
   3 1 (4.8) 0 (0)
M >0.99
   0 21 (100.0) 17 (100.0)
   1 0 (0) 0 (0)
Pathological stage 0.71
   I 15 (71.4) 12 (70.6)
   II 4 (19.0) 3 (17.6)
   III 1 (4.8) 2 (11.8)
   IV 1 (4.8) 0 (0)
Residual tumor classification 0.65
   R0 18 (85.7) 15 (88.2)
   R1 2 (9.5) 2 (11.8)
   R2 1 (4.8) 0 (0)
Length of stay (days) 19.5±7.5 20.3±8.0 0.68
30-day complications 5 (23.8) 4 (23.5) 0.98

Continuous data are presented as the mean ± standard deviation. Categorical data were expressed as counts and percentages. Group A: traditional mediastinoscopy combined with multi-port laparoscopy; Group B, modified secondary mediastinoscopy combined with “SI + 1” laparoscopy. AC, adenocarcinoma; ASA, American Society of Anesthesiologists; BMI, body mass index; SCC, squamous cell carcinoma; SI + 1, single-incision plus one-port.